Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-857-3 | CAS number: 127-68-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
Acute oral toxicity dose (LD50) of test chemical was considered based on the different experimental studies conductred on rats, All these studies concluded that the LD50 is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the test chemical cannot be classified for acute oral toxicity.
Acute Inhalation toxicity:
Acute Inhalation toxicity dose (LC50) for test chemical was considered based experimental study conducted on rat is >5.1 mg/L (>5100 mg/m3). Thus, comparing this value with the criteria of CLP regulation, the test chemical cannot be classified for acute Inhalation toxicity.
Acute Dermal toxicity:
The acute dermal toxicity dose (LD50) was considered based on different studies conducted on rats for the test chemical. The studies concluded that LD50 value is >2000 mg/kg bw, for acute dermal toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- Data is from experimental study report.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Acute oral toxicity study for test chemical in rat.
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Mean body weight was 180 and 220 g for male dose groups 5000 and 2150, respectively, and 170 g for the two female dose groups.
Fasting period: 15 - 20 h before application - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- not specified
- Doses:
- 2150, 5000 mg/kg b.w.
- No. of animals per sex per dose:
- 5 (sex/dose)
- Control animals:
- not specified
- Details on study design:
- The substance was applied as a single oral dose as a 10 mL suspension. The post-exposure period was 14 days after which the animals were sacrificed and subjected to a gross-pathological examination.
- Statistics:
- not specified
- Preliminary study:
- not specified
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no other details available
- Mortality:
- No mortality was observed at 5000 mg/kg bw.
- Clinical signs:
- other: Staggering was the only clinical symptom noted at the dose level of 5000 mg/kg b.w.
- Gross pathology:
- Gross pathology did not reveal any abnormal findings. Both sexes showed comparable results.
- Other findings:
- not specified
- Interpretation of results:
- other: Not classified
- Conclusions:
- The above experimental results prove that the LD50 value for male and female rats was determined to be >5000 mg/kg b.w. Thus, test chemical is not expected to exhibit acute oral toxicity upto the dose levels mentioned in the present study
- Executive summary:
Acute oral toxicity study was conducted according to OECD Guideline 401 (Acute Oral Toxicity) by using test chemical in 20 male and female Sprague-Dawley rats at the dose concentration of 2150 and 5000 mg/kg bw. The substance was applied as a single oral dose as a 10 mL suspension in CMC (carboxymethyl cellulose). The post-exposure period was 14 days after which the animals were sacrificed and subjected to a gross-pathological examination. No mortality was observed at 5000 mg/kg bw. Staggering was the only clinical symptom noted at the dose level of 5000 mg/kg b.w. Body weight changes was observed. Gross pathology did not reveal any abnormal findings. Both sexes showed comparable results. Therefore, LD50 was considered to be >5000 mg/kg bw, when 20 male and female Sprague-Dawley rats were treated with test chemical via oral gavage route.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from experimental study report.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Justification for type of information:
- Data is from experimental study report.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Principles of method if other than guideline:
- Acute Inhalation Toxicity of test chemical in rat.
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Mean body weight at the beginning of the study: male animals 262 +/- 7.5 g, female animals 185 +/- 3.3 g.
Age of the animals at the beginning of the study: approx . 8- 9 weeks
The animals were identified by color marking on the tail.
The animals were offered KLIBA rat/mouse laboratory diet and drinking water ad libitum during the post-exposure observation period.
The animals were kept in fully air-conditioned rooms in which a temperature in the range 20-24°C and relative humidity in the range 30-70% were regulated by means of a central air-conditioning system.
The animals were housed in groups of five in cages type D III of Becker, without bedding, with a light/dark rhythm of 12 hours. - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- not specified
- Remark on MMAD/GSD:
- not specified
- Details on inhalation exposure:
- The animals were restrained in tubes and their snouts projected into the inhalation chamber. The dust aerosol air mixture was generated with a dosing-wheel dust generator and the concentration was adjusted by varying the rotation of the metering disc. Air-flow was 1,500 l/h while the temperature was kept between 19 and 25°C. The limit-test procedure was applied.
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Remarks on duration:
- not specified
- Concentrations:
- 5.1 mg/L
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology - Statistics:
- The statistical evaluation of the concentration/effect relationship was carried out on the basis of the binomial test (Wittig, H.: Mathematische Statistik 1974, pp . 32 - 35) in accordance with tables of the BASF Computer Center.
- Preliminary study:
- not specified
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.1 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: no mortalities
- Mortality:
- No mortality was observed in treated rats.
- Clinical signs:
- other: Clinical examination reveiled 10/10 animals with eyelid closure over the whole course of the exposure period. Temporarily, 4/10 animals showed irregular respiration, 7/10 accelerated respiration, 3/10 intermittent respiration, 3/10 whooping respiration, 7
- Body weight:
- The body weight gain of male rats in the test group, compared with a historical control collective, was not affected by the substance over the total observation period.
The body weight gain of female rats in the test group, compared with a historical control collective, was slightly retarded in the second week of the observation period. - Gross pathology:
- Sacrificed animals (males and females): no pathologic findings noted.
- Other findings:
- not specified
- Interpretation of results:
- other: Not classified
- Conclusions:
- Under the experimental conditions chosen, the combined LC50 for test chemical (aerosol) was >5.1 mg/L. Also, from day 2 of the observation period onward, 10/10 animals were without findings. Hence it is concluded that the chemical is not expected to exhibit acute toxicity by the inhalation route. However, the substance is expected to be an irritant to the respiratory tract at high concentrations.
- Executive summary:
Acute Inhalation Toxicity study was conducted according to OECD Guideline 403 (Acute Inhalation Toxicity) by using test chemical in 10 male and female Wistar rats at the concentration of 5.1 mg/L via nose/head only inhalation by aerosol route for 4 hours exposure. The animals were restrained in tubes and their snouts projected into the inhalation chamber. The dust aerosol air mixture was generated with a dosing-wheel dust generator and the concentration was adjusted by varying the rotation of the metering disc. Air-flow was 1,500 l/h while the temperature was kept between 19 and 25°C. The limit-test procedure was applied. Animals were observed for mortality and clinical signs for 14 days. The statistical evaluation of the concentration/effect relationship was carried out on the basis of the binomial test (Wittig, H.: Mathematische Statistik 1974, pp . 32 - 35) in accordance with tables of the BASF Computer Centre. No mortality was observed in treated rats. Clinical examination reviled 10/10 animals with eyelid closure over the whole course of the exposure period. Temporarily, 4/10 animals showed irregular respiration, 7/10 accelerated respiration, 3/10 intermittent respiration, 3/10 whooping respiration, 7/10 shallow respiration, 3/10 salivation, 10/10 restlessness and 10/10 attempts to escape. On day 1 of the post-exposure period, 6/10 animals showed a reddish smear and crusts on their noses and 7/10 animals had fur discoloured with test substance. From day 2 of the observation period onward, 10/10 animals were without findings. Body weight change was observed. In sacrificed animals (males and females) no pathologic findings were noted. Hence, LC50 was considered to be >5.1 mg/L (>5100 mg/m3), when 10 male and female Wistar rats were exposed with test chemical via nose/head only inhalation by aerosol route for 4 hours exposure.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 5 100 mg/m³ air
- Quality of whole database:
- Data is Klimisch 2 and from experimental study report.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- experimental data from various test chemicals
- Justification for type of information:
- Data is summarized based on the available information from various test chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- WoE report is based on 3 acute dermal toxicity studies as- WoE 2, WoE 3 and WoE 4
Acute dermal toxicity test was carried out to study the effects of the test chemicals on rodents. - GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 1.TEST ANIMALS
- Source: National Institute of Biosciences, Pune.
- Females (if applicable) nulliparous and non-pregnant: No data available
- Age at study initiation: Young adult male and female rats aged between 6 – 9 weeks were used.
- Weight at study initiation: The weight ranges of approximately 239.3 to 272.5 grams at initiation of dosing were used.
Body weights at the start :
Male
Mean : 270.14 g (= 100 %)
Minimum : 267.1 g (- 1.13 %)
Maximum : 272.5 g (+ 0.87 %)
Total No. of animals : 5
Female
2.Mean : 243.94 g (= 100 %)
4.Mean : 249.20 g (= 100 %)
2.Minimum : 239.3 g (- 1.90 %)
4.Maximum : 250.1 g (+ 2.53 %)
Minimum : 243.9 g (- 2.13 %)
Maximum : 255.3 g (+ 2.45 %)
Total No. of animals : 5
- Fasting period before study: No data available
- Housing: The rats were individually housed in polycarbonate cages with paddy husk as bedding.
- Diet (e.g. ad libitum): Rodent feed supplied by the Nutrivet Life Sciences, Pune, was provided ad libitum from individual feeders.
- Water (e.g. ad libitum): Water was provided ad libitum from individual bottles attached to the cages. All water was from a local source and passed through the reverse osmosis membrane before use.
- Acclimation period: 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.1 to 22.3 degree centigrade.
3.- Humidity (%): 55.7% to 59.6%.
4.- Humidity (%): 53.2% to 58.8%
- Air changes (per hr): Ten to fifteen air changes per hour.
- Photoperiod (hrs dark / hrs light): An artificial light and dark cycle of 12 hours each was provided to the room. - Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Trunk (dorsal surface and sides from scapular to pelvic area)
- % coverage: Approximately 10% of the total body surface area.
- Type of wrap if used: Porous gauze dressing and non-irritating tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Distilled water was used to remove residual test item.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw
- Constant volume or concentration used: No data available
- For solids, paste formed: Yes
VEHICLE
- Amount(s) applied (volume or weight with unit): No data available
- Concentration (if solution): No data available
- Lot/batch no. (if required): No data available
- Purity: No data available - Duration of exposure:
- 24 hours
- Doses:
- A single dose of 2000 mg of the test item per kilogram of body weight was administered to ten rats (five males and five females).
- No. of animals per sex per dose:
- 10 (5/sex).
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Twice daily
- Necropsy of survivors performed: Yes
- Other examinations performed:
Clinical Observations and General Appearance:
Animals were observed for clinical signs, mortality, until sacrifice.
Onset, duration and severity of any sign were recorded. The clinical signs and mortality observations were conducted at 10, 30, 60 minutes, 2, 4 and 6 hours on the day of dosing and once daily thereafter for 14 day. Daily observation was done as far as possible at the same time.
The observations were included general clinical signs, observations of eyes, mucous membranes, respiratory, circulatory system and behavior pattern.
Evaluation of Dermal Reaction:
Dermal reaction was observed daily for study period of 14 days.
Body weights:
Individual animal body weights were recorded pre-test (prior to administration of the test item), day 7 and at termination on day 14.
Gross Pathology:
Necropsy was performed on animals surviving at the end of the study. Macroscopic examination of all the orifices, cavities and tissues were made and the findings were recorded. All animals surviving the study period were sacrificed by the carbon dioxide asphyxiation technique (day 15).
Histopathology:
No gross abnormalities were observed in animals sacrificed terminally hence, no histopathology was performed. - Statistics:
- No data
- Preliminary study:
- No data
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no other details available
- Mortality:
- 2. Sex : Male
Group I -
Animal treated at the dose level of 2000 mg/kg: All animals survived through the study period of 14 days.
Sex : Female
Group I –
Animal treated at the dose level of 2000 mg/kg: All animals survived through the study period of 14 days.
3.Sex : Male
Group I -
Animal treated at the dose level of 2000 mg/kg: All animals survived through the study period of 14 days.
Sex : Female
Group I –
Animal treated at the dose level of 2000 mg/kg: All animals survived through the study period of 14 days.
4.Sex : Male
Group I -
Animal treated at the dose level of 2000 mg/kg body weight: All animals survived through the study period of 14 days.
Sex : Female
Group I -
Animal treated at the dose level of 2000 mg/kg body weight: All animals survived through the study period of 14 days. - Clinical signs:
- other: 2.Sex : Male Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any signs of toxicity during the study period of 14 days. Sex : Female Group I - Animal treated at the dose level of 2000 mg/kg body weight did not res
- Gross pathology:
- Gross pathological examination did not reveal any abnormalities in animals from 2000 mg/kg dose group.
- Other findings:
- 2.- Other observations:
Evaluation of Dermal Reaction
Sex : Male
Group I -
Animal treated at the dose level of 2000 mg/kg body weight did not result in any skin reaction during the study period of 14 days.
Sex : Female
Group I -
Animal treated at the dose level of 2000 mg/kg body weight did not result in any skin reaction during the study period of 14 days. - Interpretation of results:
- other: Not classified
- Conclusions:
- According to CLP regulation, the test chemical cannot be classified for acute dermal toxicity, as the LD50 value is >2000 mg/kg bw.
- Executive summary:
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats for test chemical. The studies are summarized as below –
The reported study was designed and conducted to determine the acute dermal toxicity profile of test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. It was concluded that the acute dermal median lethal dose (LD50) of test chemical, when administered to male and female Sprague Dawley rats was found to be >2000 mg/kg body weight. Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant. CLP Classification: “Not classified”.
The above study is supported with another study conducted to determine the acute dermal toxicity profile of test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. It was concluded that the acute dermal median lethal dose (LD50) of test chemical, when administered to male and female Sprague Dawley rats was found to be >2000 mg/kg body weight. Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant. CLP Classification: “Not classified”.
The above study is supported with another study conducted on rats The study now reported was designed and conducted to determine the acute dermal toxicity profile of test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days.
Animals exhibited normal body weight gain through the study period of 14 days.
Gross pathological examination did not reveal any abnormalities attributable to the treatment.
It was concluded that the acute dermal median lethal dose (LD50) of test chemical , when administered to male and female Sprague Dawley rats was found to be greater than 2000 mg/kg body weight.Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 794 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from study report
Additional information
Acute oral toxicity:
The experimental study conducted by and was designed for the acute oral toxicity of test chemical according to OECD Guideline 401 (Acute Oral Toxicity) in 20 male and female Sprague-Dawley rats at the dose concentration of 2150 and 5000 mg/kg bw. The substance was applied as a single oral dose as a 10 mL suspension in CMC (carboxymethyl cellulose). The post-exposure period was 14 days after which the animals were sacrificed and subjected to a gross-pathological examination. No mortality was observed at 5000 mg/kg bw. Staggering was the on ly clinical symptom noted at the dose level of 5000 mg/kg b.w. Body weight changes was observed. Gross pathology did not reveal any abnormal findings. Both sexes showed comparable results. Therefore, LD50 was considered to be >5000 mg/kg bw, when 20 male and female Sprague-Dawley rats were treated with test chemical via oral gavage route.
The above study is supported by another experimental study conducted and was designed for the acute oral toxicity according to BASF-internal standard by using test chemical in 10 male and female Tuebinger mice at the dose concentration of 3200 mg/kg bw. The substance was applied as a single oral dose as a 30% in water. No mortality was observed at 3200 mg/kg bw. No abnormalities detected in treated mice. Therefore, LD50 was considered to be >3200 mg/kg bw, when 10 male and female Tuebinger mice were treated with test chemical via oral route.
The above experimental studies are also supported for the test chemical for the acute oral toxicity in rats at the concentration of 5000 mg/kg bw. No mortality was observed at dose 5000 mg/kg bw. Hence LD50 was considered to be >5000mg/kg bw, when rats were treated with test chemical via oral route.
All the above studies are further supported by test chemical, for acute oral toxicity conducted in rats at the concentration of 11000 mg/kg bw. 50% mortality was observed at dose 11000 mg/kg bw. Hence LD50 was considered to be 11000 mg/kg bw, when rats were treated with Sodium 3-nitrobenzenesulphonate (CAS no: 127-68-4test chemical via oral route.
Thus, based on the above studies,it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, test chemical cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
The experimental study conducted was designed for the acute inhalation toxicity of test chemical according to OECD Guideline 403 (Acute Inhalation Toxicity) in 10 male and female Wistar rats at the concentration of 5.1 mg/L via nose/head only inhalation by aerosol route for 4 hours exposure. The animals were restrained in tubes and their snouts projected into the inhalation chamber. The dust aerosol air mixture was generated with a dosing-wheel dust generator and the concentration was adjusted by varying the rotation of the metering disc. Air-flow was 1,500 l/h while the temperature was kept between 19 and 25°C. The limit-test procedure was applied. Animals were observed for mortality and clinical signs for 14 days. The statistical evaluation of the concentration/effect relationship was carried out on the basis of the binomial test (Wittig, H.: Mathematische Statistik 1974, pp . 32 - 35) in accordance with tables of the BASF Computer Centre. No mortality was observed in treated rats. Clinical examination reviled 10/10 animals with eyelid closure over the whole course of the exposure period. Temporarily, 4/10 animals showed irregular respiration, 7/10 accelerated respiration, 3/10 intermittent respiration, 3/10 whooping respiration, 7/10 shallow respiration, 3/10 salivation, 10/10 restlessness and 10/10 attempts to escape. On day 1 of the post-exposure period, 6/10 animals showed a reddish smear and crusts on their noses and 7/10 animals had fur discoloured with test substance. From day 2 of the observation period onward, 10/10 animals were without findings. Body weight change was observed. In sacrificed animals (males and females) no pathologic findings were noted. Hence, LC50 was considered to be >5.1 mg/L (>5100 mg/m3), when 10 male and female Wistar rats were exposed with test chemical via nose/head only inhalation by aerosol route for 4 hours exposure.
Thus, based on the above study on test chemical, it can be concluded that LC50 value is >5 mg/L air. Thus, comparing this value with the criteria of CLP regulation, test chemical cannot be classified for acute Inhalation toxicity.
Acute Dermal toxicity:
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats for structurally similar read across chemicals.The studies are summarized as below –
The reported study was designed and conducted to determine the acute dermal toxicity profile of test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. It was concluded that the acute dermal median lethal dose (LD50) of test chemical, when administered to male and female Sprague Dawley rats was found to be >2000 mg/kg body weight. Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant. CLP Classification: “Not classified”.
The above study is supported with another study conducted to determine the acute dermal toxicity profile of test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. It was concluded that the acute dermal median lethal dose (LD50) of test chemical, when administered to male and female Sprague Dawley rats was found to be >2000 mg/kg body weight. Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant. CLP Classification: “Not classified”.
The above study is supported with another study conducted on rats The study now reported was designed and conducted to determine the acute dermal toxicity profile of test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days.
Animals exhibited normal body weight gain through the study period of 14 days.
Gross pathological examination did not reveal any abnormalities attributable to the treatment.
It was concluded that the acute dermal median lethal dose (LD50) of test chemical , when administered to male and female Sprague Dawley rats was found to be greater than 2000 mg/kg body weight.Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw, for acute oral and acute dermal toxicity and LC50 to be 5100 mg/m3 for acute inhalation toxicity,Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral, acute dermal and acute inhalation toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.